Search

everythinglearnresearchcommunity

for

Search:↓

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Finasteride significantly reduces fertility in male rats.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Finasteride reduces prostate size and DHT in male mastomys but not in females.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

New steroids were effective in blocking male hormone receptors in hamster prostates.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Silver nanoparticles from Mitracarpus scaber protect the liver and reduce prostate enlargement.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Dosing time affects finasteride's effectiveness and safety in rats.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

Men with higher body mass index (BMI) in Taiwan tend to have more severe hair loss.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Finasteride affects prostate weights and pituitary activity differently with age.